StockEdge.com
  • Products
    • StockEdge Premium
    • StockEdge Pro
    • StockEdge Club
    • Compare Plans
StockEdge Blog
  • Trending Stocks
  • Insights
    • All
    • Business Houses
    • Markets themes
    • Stock Insights
    Zomato Shares

    Zomato Shares/Stock Analysis: Profile, Financials & Growth

    Aster DM Healthcare’s Spinoff of Gulf Hospitals – A Special Situation You Can’t Afford to Miss!

    Aster DM Healthcare’s Spinoff of Gulf Hospitals – A Special Situation You Can’t Afford to Miss!

    An image charging the electric vehicle from e-station and Text written on the right side

    India’s Top Electric Vehicle(EV) Stocks

    Top 5 Textile stocks

    Top 5 Textile Stocks in India: From Cotton to Cash

    multi-bagger stocks for 2025

    5 Multibagger Stocks to keep an eagle-eye for 2025

    Jindal Saw – Strong Earnings Momentum Ahead

    Jindal Saw – Strong Earnings Momentum Ahead

    Kirloskar Group- A Legacy of 134 Years

    Kirloskar Group- A Legacy of 134 Years

    renewable energy stocks in india

    Top Renewable Energy Stocks in India

    blue chip stocks

    Top 5 Blue Chip Stocks to Buy and Invest in 2023

  • Technical Analysis
    Chart Patterns – Holy grail of Stock Market Analysis

    Chart Patterns – Holy grail of Stock Market Analysis

    StockEdge Version Update : 9.0

    StockEdge Version Update : 9.0

    Beat the street with Sector Rotation Strategy

    Beat the street with Sector Rotation Strategy

    StockEdge Version Update 8.2

    StockEdge Version Update 8.2

    Derivative Analytics

    An Insightful Research Tool For Derivative Analytics

    Introducing Put-Call Ratio a Derivative Indicator in the Market

    Introducing Put-Call Ratio a Derivative Indicator in the Market

    A Powerful Technical Indicator Beta & Beta Scans

    A Powerful Technical Indicator Beta & Beta Scans

    Technical Analysis using Edge Charts

    Technical Analysis using Edge Charts

    adaptive relative strength and static relative strength scans

    What is Adaptive Relative Strength & Static Relative Strength Scans?

  • Fundamental Analysis
    • All
    • Cash Flow Ratios
    • Efficiency ratios
    • Growth Ratios
    • Liquidity Ratios
    • Return Ratios
    • Solvency ratios
    • Valuation Ratios
    high dividend paying stocks

    Identifying High Dividend Paying Stocks

    Understanding the Importance of creating Fundamental Scans

    Understanding the Importance of creating Fundamental Scans

    Using My Combination Scan to Identify best in an Industry

    Using My Combination Scan to Identify best in an Industry

    Cost Income ratio

    Cost to Income Ratio(%)

    Cost of Liability

    Cost of Liabilities (%)

    Operating Cost to Assets Ratio (%)

    Operating Cost to Assets Ratio (%)

  • StockEdge Tutorials
    Simplify stock market analysis with Edge Reports | StockEdge

    Simplify stock market analysis with Edge Reports | StockEdge

    StockEdge Club: An Exclusive Investors Hub & Analytics platform

    StockEdge Club: An Exclusive Investors Hub & Analytics platform

    FII/DII Data: Leading Indicators of Stock Market

    FII/DII Data: Leading Indicators of Stock Market

    Chart Patterns – Holy grail of Stock Market Analysis

    Chart Patterns – Holy grail of Stock Market Analysis

    StockEdge Version Update : 9.0

    StockEdge Version Update : 9.0

    Powerful Investment Themes for Retail Investors

    Powerful Investment Themes for Retail Investors

    Beat the street with Sector Rotation Strategy

    Beat the street with Sector Rotation Strategy

    StockEdge Version Update 8.3

    StockEdge Version Update 8.3

    StockEdge Version Update 8.2

    StockEdge Version Update 8.2

  • Mutual Fund
    Top 5 Mutual Funds for 2022 where you can start your SIP

    Top 5 Mutual Funds for 2022 where you can start your SIP

    What are Value Funds and its Advantages?

    What are Value Funds and its Advantages?

    thematic funds

    Thematic Funds : Everything you need to know

    Understanding Sector Funds and their Benefits to our Portfolio

    Understanding Sector Funds and their Benefits to our Portfolio

    Are Dividend Yield Funds a good option to invest in?

    Are Dividend Yield Funds a good option to invest in?

    What are Contra Funds and their advantages?

    What are Contra Funds and their advantages?

    Trending Tags

    No Result
    View All Result
    • Trending Stocks
    • Insights
      • All
      • Business Houses
      • Markets themes
      • Stock Insights
      Zomato Shares

      Zomato Shares/Stock Analysis: Profile, Financials & Growth

      Aster DM Healthcare’s Spinoff of Gulf Hospitals – A Special Situation You Can’t Afford to Miss!

      Aster DM Healthcare’s Spinoff of Gulf Hospitals – A Special Situation You Can’t Afford to Miss!

      An image charging the electric vehicle from e-station and Text written on the right side

      India’s Top Electric Vehicle(EV) Stocks

      Top 5 Textile stocks

      Top 5 Textile Stocks in India: From Cotton to Cash

      multi-bagger stocks for 2025

      5 Multibagger Stocks to keep an eagle-eye for 2025

      Jindal Saw – Strong Earnings Momentum Ahead

      Jindal Saw – Strong Earnings Momentum Ahead

      Kirloskar Group- A Legacy of 134 Years

      Kirloskar Group- A Legacy of 134 Years

      renewable energy stocks in india

      Top Renewable Energy Stocks in India

      blue chip stocks

      Top 5 Blue Chip Stocks to Buy and Invest in 2023

    • Technical Analysis
      Chart Patterns – Holy grail of Stock Market Analysis

      Chart Patterns – Holy grail of Stock Market Analysis

      StockEdge Version Update : 9.0

      StockEdge Version Update : 9.0

      Beat the street with Sector Rotation Strategy

      Beat the street with Sector Rotation Strategy

      StockEdge Version Update 8.2

      StockEdge Version Update 8.2

      Derivative Analytics

      An Insightful Research Tool For Derivative Analytics

      Introducing Put-Call Ratio a Derivative Indicator in the Market

      Introducing Put-Call Ratio a Derivative Indicator in the Market

      A Powerful Technical Indicator Beta & Beta Scans

      A Powerful Technical Indicator Beta & Beta Scans

      Technical Analysis using Edge Charts

      Technical Analysis using Edge Charts

      adaptive relative strength and static relative strength scans

      What is Adaptive Relative Strength & Static Relative Strength Scans?

    • Fundamental Analysis
      • All
      • Cash Flow Ratios
      • Efficiency ratios
      • Growth Ratios
      • Liquidity Ratios
      • Return Ratios
      • Solvency ratios
      • Valuation Ratios
      high dividend paying stocks

      Identifying High Dividend Paying Stocks

      Understanding the Importance of creating Fundamental Scans

      Understanding the Importance of creating Fundamental Scans

      Using My Combination Scan to Identify best in an Industry

      Using My Combination Scan to Identify best in an Industry

      Cost Income ratio

      Cost to Income Ratio(%)

      Cost of Liability

      Cost of Liabilities (%)

      Operating Cost to Assets Ratio (%)

      Operating Cost to Assets Ratio (%)

    • StockEdge Tutorials
      Simplify stock market analysis with Edge Reports | StockEdge

      Simplify stock market analysis with Edge Reports | StockEdge

      StockEdge Club: An Exclusive Investors Hub & Analytics platform

      StockEdge Club: An Exclusive Investors Hub & Analytics platform

      FII/DII Data: Leading Indicators of Stock Market

      FII/DII Data: Leading Indicators of Stock Market

      Chart Patterns – Holy grail of Stock Market Analysis

      Chart Patterns – Holy grail of Stock Market Analysis

      StockEdge Version Update : 9.0

      StockEdge Version Update : 9.0

      Powerful Investment Themes for Retail Investors

      Powerful Investment Themes for Retail Investors

      Beat the street with Sector Rotation Strategy

      Beat the street with Sector Rotation Strategy

      StockEdge Version Update 8.3

      StockEdge Version Update 8.3

      StockEdge Version Update 8.2

      StockEdge Version Update 8.2

    • Mutual Fund
      Top 5 Mutual Funds for 2022 where you can start your SIP

      Top 5 Mutual Funds for 2022 where you can start your SIP

      What are Value Funds and its Advantages?

      What are Value Funds and its Advantages?

      thematic funds

      Thematic Funds : Everything you need to know

      Understanding Sector Funds and their Benefits to our Portfolio

      Understanding Sector Funds and their Benefits to our Portfolio

      Are Dividend Yield Funds a good option to invest in?

      Are Dividend Yield Funds a good option to invest in?

      What are Contra Funds and their advantages?

      What are Contra Funds and their advantages?

      Trending Tags

      No Result
      View All Result
      StockEdge Blog
      Home Insights
      Thyrocare Technologies Ltd. – India’s first fully automated diagnostic laboratory

      Thyrocare Technologies Ltd. – India’s first fully automated diagnostic laboratory

      StockEdge by StockEdge
      July 18, 2021
      Reading Time: 8 mins read
      5.4k
      VIEWS
      Share on FacebookShare on TwitterShare On WhatsApp

      Table of Contents

      • The Deal
      • How is the deal going to benefit both sides?
      • Operational Highlights
      • Future Outlook
      • Management Update
      • Technical View
      • Conclusion

      The digital healthcare space is consolidating at a rapid pace, and everyone wants a slice of the pie. With such big Business Houses like Tata & Reliance, entering into e-pharmacy (Tata Digital bought 60% stake in 1MG, Reliance bought a 60% stake in Netmeds.) to fill gaps in their portfolios, PharmEasy also recently bought the promoter stake in Thyrocare, one of India’s largest diagnostic chains. This was India’s first acquisition of a publicly traded company by a unicorn startup. Before we try to understand the benefits of this deal to both the acquirer and acquiree, let us know about both sides.

      Founded by A. Velumani in 1996, Thyrocare Technologies is India’s first and most advanced Totally Automated Laboratory having its strong presence across India and worldwide with the goal of providing high-quality services at affordable prices to laboratories and hospitals in India and other countries.

       
      Thyrocare Technologies Ltd.

      It has a Centralized Processing Laboratory (CPL) for esoteric tests in Mumbai, India, as well as Regional Processing Laboratories in major Indian cities and other parts of Asia.

      Thyrocare Technologies Ltd. is India’s fourth-largest diagnostics chain, specialising in low-cost pathological biochemical testing. It operates on a low-cost business model to make wellness and preventive care affordable and accessible to all citizens in order to promote healthy living. It focuses on strong technologies, brands, and systems that enable all of its laboratories to maintain global standards in quality service at cost-effective prices. It has built a solid B2B model by servicing laboratories, hospitals, and doctors, as well as catering to individual patients’ needs.

      Thyrocare Technologies Ltd.

      Nueclear Healthcare Limited (Nueclear) is a wholly owned subsidiary that provides cancer-related diagnostic testing (PETCT) at low cost in 13 cities.

      Digitization has become an essential component of the healthcare industry in India. Every step in the industry has been digitised, from scheduling a doctor’s appointment to delivering reports and medicines. And e-pharmacies like PharmEasy deserve a lot of credit for that.

      Founded by Dhaval Shah & Dharmil Sheth in 2014, PharmEasy is an online medical platform . which enables users to order pharmaceutical and healthcare products. It has 12 million users, 6,000 digital consultation clinics, and 90,000 partner retailers across the country. The company had recently acquired Medlife to become India’s largest e-pharmacy player with approximately 60% market share. As of today’s date, this is Thyrocare Technologies Ltd share price

      The Deal

      On June 25 2021, PharmEasy announced the acquisition of a 66.1% stake in diagnostic chain Thyrocare Technologies Ltd. API Holdings Ltd., PharmEasy’s parent company, confirmed the “signing of definitive documents” for a deal worth Rs. 4,546 crores in an official statement on Friday.

      DocOn Technologies Pvt. Ltd., a subsidiary of PharmEasy’s parent API, will pay Rs. 1,300 per share to acquire the stakes from Thyrocare’s chairman and MD, Dr A Velumani, and affiliates. As a result of this acquisition, DocOn will make an open offer for an additional 26% stake in order to strengthen and diversify its business. Velumani will also acquire a non-controlling stake in API Holdings worth less than 5%, according to the exchange filing. This will require an investment of approximately Rs. 1,500 crores.

      How is the deal going to benefit both sides?

      The deal is backed by investors like CDPQ, LGT Lightrock, and Temasek. The primary goal of this deal, according to PharmEasy, is to “create a one-stop shop for end-to-end healthcare solutions.” On the other hand, Mr. Velumani’s children have no plans to take over the family business. The promoter attempted to hire professional management as CEO, but he resigned after only a few months for personal reasons.Therefore, It was the right time and right way to exit as per Mr. Velumani.

      Operational Highlights

      • FY21 revenue increased by 14% YoY to ₹495cr, highest since inception.
      • EBITDA stood at ₹171cr almost flat YoY.
      • PAT at ₹113cr increased by 28% YoY.
      • EBITDA & PAT margins reverting to more sustainable pre-Covid levels.
      • Performed more than 10.44 lakhs COVID tests as of financial year-end.
      • Profit from sale of business undertakings at Jaipur was reported as other income.
      • Significant revival of the preventive care business in the current quarter, which took a hit in  previous quarters due to pandemic.
      • State governments have imposed strict controls on the prices of Covid RTPCR tests, resulting in significantly lower realisation per test. This has resulted in a decrease in the topline from the Covid business, despite the fact that volume has increased sequentially.
      • However, controlled prices of tests has not affected their margins because of their negotiations in  reagent/consumable costs and control in other operating costs.
      • Scans performed in prominent centers improved gradually. Total number of scans performed stood at 16,011.
      • Employees benefit expenses have increased due to increased head counts, better incentives to  staff during COVID and increase in provisions.
      • Zonal Processing Laboratory at Delhi & Bangalore commenced operations in the current quarter.
      • Lucknow and Kochi regional processing laboratories are ready to commence operations.
      Thyrocare Technologies Ltd.

      Future Outlook

      • Kolkata Zonal Processing Laboratory is likely to commission in Q1FY22.
      • Radiology business will likely revive rapidly after lockdown since most of the PETCT centers are  fully functional now.
      • The gradual improvement in the logistics situation would provide a further recovery in their non-  COVID revenues.
      • TTL’s initiative to launch tuberculosis testing through dedicated ‘Focus TB’ has gained traction and  it intends to expand footprints in other parts of the country by replicating its laboratory business  model.
      • The company has also secured licenses in April 2019, to launch non-invasive prenatal testing  (NIPT) and next generation sequencing (NGS); which provides a safer method compared to  invasive procedures that involve risks of miscarriage and determine the health of fetus. They will  review this segment and look to expand also.
      • Arogyam packages are offered at lucrative prices which TTL could leverage to boost volumes.
      • It has deployed more than 120 field sales executives, adding strength to its customer reach.
      • Revenue contribution from B2B is 77%, which focuses on volumes.

      Management Update

      • An  upcoming  facility  in  Ambernath,  Mumbai  with  cost  around   ₹27cr  is  scheduled  to  be  commissioned by Q1 FY22.
      • Preparing for the next phase of growth by focusing on expanding its branded franchise centres, with plans to add 50 new ones.
      • Management is confident of providing better accessibility to clients of Thyrocare with their  planned changes ahead.
      • After relocating the equipment from Coimbatore, the Borivali centre began operations in the current quarter.

      Technical View

      Thyrocare Technologies is trading in narrow range whereas Technical indicators are mild bullish, nearby resistance is swing high of 1465, if price trades above 1465 level, next Fibonacci resistance is 1629-1743 and 1856, support is at 1260 and previous breakout point is 1212 on daily chart.

      Thyrocare Technologies Ltd.

      Conclusion

      Thyrocare used the Hub & Spoke model to expand its reach by establishing Centralised Processing  Laboratory (CPL) & Regional Processing laboratory (RPL) across various cities in India. This type of  asset light business model allows them to operate at substantial lower cost. Henceforth, margins are  lucrative for Thyrocare as they attain economies of scale by collecting more samples from Authorised  Service Providers (ASPs).

      Thyrocare’s wholly-owned subsidiary Nueclear has 11 operating PET-CT scanners, which has a high  margin profile. As of March 31, 2020, it had a total of 44,645 touchpoints, with 4,410 B2B partners spread across 796 cities in India. These numbers are bound to increase as small unorganized  players consolidate into an organized manner. Possibly, it will be due to not achieving economies of  scale over the long run. Arogyam will gradually acquire more customers because of their lower priced  preventive healthcare tests. Licenses for new tests and commencing operations will aid in top-line  growth.

      With Free Cash Flow of ₹109cr, the company is at a comfortable position to expand its reach throughout the country and add more centers. Cost of consumables and employee benefit expenses are controlled  by shifting scanners on franchisee arrangement. Recovery of both pathology and radiology business  over next quarters will enable the company to sustain the margin.

      Know more about Thyrocare Technologies Ltd. and its peers by using the Sectors tab in the StockEdge Web

      Check out StockEdge Premium Plans.

      Disclaimer: This document and the process of identifying the potential of a company has been produced for only learning  purpose. Since equity involves individual judgments, this analysis should be used for only learning enhancements  and cannot be considered to be a recommendation on any stock or sector.

      Tags: Diagnostics IndustryFY 21 ResultsPharmEasy Thyrocare Deal
      ShareTweetSend
      Subscribe On Telegram Subscribe On Telegram Subscribe On Telegram
      Previous Post

      Trending Stocks – Angel Broking Ltd.

      Next Post

      Trending Stocks – HDFC Bank Ltd.

      StockEdge

      StockEdge

      StockEdge is a self-help Equity and Mutual Fund research tool. It empowers retail investors to identify investment opportunity with all the necessary data and analytics.

      Next Post
      Trending Stocks – HDFC Bank Ltd.

      Trending Stocks – HDFC Bank Ltd.

      Trending Stocks – ACC Ltd.

      Trending Stocks – ACC Ltd.

      Trending Stocks – Gland Pharma Ltd.

      Trending Stocks – Gland Pharma Ltd.

      Comments 2

      1. Manohar hemnani says:
        2 years ago

        Nice pick

      2. Dharmendrakumar Dhirubhai Chavda says:
        2 years ago

        Good

      Contact Us
      • Timing (Mon-Sat): 10 am to 7 pm
      • Sales: +919830994463
      • Support: +919830994402
      • Club Support: +916289906895
      • Affiliate: +917003567131
      Recent Posts
      All About NIFTY50, Components of NIFTY50, and How to Invest in it
      Simplify stock market analysis with Edge Reports | StockEdge
      Important Links
      • StockEdge.com
      • StockEdge Premium
      • - Quarterly Membership
      • - Annual Membership
      • StockEdge Analyst
      • StockEdge Club
      • Compare Plans
      An Initiative Of

      © 2023 Kredent InfoEdge Pvt Ltd.

      Facebook-f Twitter Instagram Linkedin-in Youtube Pinterest-p

      Get StockEdge App

      No Result
      View All Result
      • Home
      • Article Categories
        • Fundamental Analysis
        • Technical Analysis
        • Market Themes
        • StockEdge Tutorials
        • StockEdge Version Updates
      • Products
        • StockEdge Premium
        • StockEdge Pro
        • StockEdge Club
        • Compare Plans
      • Visit StockEdge.com

      © 2023 Kredent InfoEdge Pvt Ltd.

      ELM School

      Premium or Pro or Club?

      The market is back in decent shape and the good time to invest in stock is finally here.
      Become a smart investor with a stunning deal! Use code DEAL30 to get any plan at 30% flat discount

      GET YOUR PLAN